Clinical trial
Dehydroepiandrosterone Administration in Women With Systemic Lupus Erythematosus…
NCT00391924 · UMC Utrecht, Other · Completed
Key facts
| NCT number | NCT00391924 |
|---|---|
| Title | Dehydroepiandrosterone Administration in Women With Systemic Lupus Erythematosus or Primary Sjögren's Syndrome |
| Official title | Fatigue and General Well-Being in Patients With Systemic Lupus Erythematosus or Primary Sjögren's Syndrome: Effects of Dehydroepiandrosterone Administration |
| Lead sponsor | UMC Utrecht, Other |
| Collaborators | University Medical Center Groningen Dutch Arthritis Association Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lupus Erythematosus, Systemic, Sjogren's Syndrome |
| Intervention type | Drug |
| Interventions | Dehydroepiandrosterone |
| Enrollment | 120 |
| Start date | May 1, 2000 |
| Completion | Jan 1, 2003 |
| First posted | Oct 25, 2006 |
| Last update posted | Oct 25, 2006 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: